The short answer
IGF binding proteins sequester the overwhelming majority of circulating IGF-1, largely in a ternary complex with IGFBP-3 and the acid-labile subunit. Bound IGF-1 cannot engage its receptor, so this system controls how much is actually available.
Key facts
- Binding protein family
- Six IGFBPs
- Dominant carrier
- IGFBP-3
- Third component
- Acid-labile subunit (ALS)
- Complex
- Ternary: IGF-1 + IGFBP-3 + ALS
- Effect
- Extends half-life, restricts availability
- Key review
- Baxter, Horm Res 1994 (PMID 7532612)
What the system does
Six IGF binding proteins bind IGF-1 with high affinity. The dominant one in circulation is IGFBP-3, which forms a ternary complex with IGF-1 and the acid-labile subunit. That assembly is too large to leave the vascular compartment easily, which both prolongs IGF-1's presence and restricts where it can act.
Why sequestration is not simply a limitation
IGF-1 is a growth factor with receptors on nearly every tissue and structural similarity to insulin. Uncontrolled availability would be a problem, not a benefit. The binding protein system functions as a reservoir and a brake at once, holding a large circulating pool while keeping the free, active fraction small and regulated.
Research material referenced
IGF-1 LR3 1mg, third-party HPLC tested
What the acid-labile subunit contributes
ALS is what makes the complex large enough to be retained in circulation. Its importance is demonstrated by what happens when it is missing: Domené and colleagues described acid-labile subunit deficiency in the Journal of Endocrinological Investigation in 2005, a condition in which the ternary complex cannot form and IGF-1 handling is substantially altered.
How LR3 evades it
Two modifications, both aimed at the same target. Arginine at position 3 replaces a glutamate whose negative charge contributes to binding protein interaction. The 13-residue N-terminal extension adds further interference. Together they substantially reduce IGFBP affinity, which raises the free fraction at a given total concentration.
What that means and does not mean
A larger free fraction means more is available to engage receptors at any moment. It does not mean more total activity in any simple sense, because the binding protein system also protects IGF-1 from clearance. Removing the reservoir function while removing the brake changes the whole profile, not just one part of it.
Why this matters for cell culture
Cultured cells secrete their own IGF binding proteins into the medium, which sequester added IGF-1 unpredictably. An analogue that resists them delivers more consistent availability from experiment to experiment. That is the practical reason LR3 exists as a laboratory reagent.
Frequently asked questions
How much circulating IGF-1 is free?
Only a small fraction. The overwhelming majority is bound, largely in the ternary complex with IGFBP-3 and the acid-labile subunit.
Why does the body sequester IGF-1?
It is a growth factor with receptors on nearly every tissue. The binding system acts as both a reservoir and a brake.
How does LR3 escape it?
Arginine at position 3 removes a charge contributing to binding, and a 13-residue N-terminal extension adds further interference.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More IGF-1 LR3 articles
- IGF-1 LR3 Structure: Three Disulfides and Why They Matter83 residues folded by three disulfide bonds. Milner 1995 showed B-domain mutations affect oxidative folding - and position 3 is in the B-domain.
- Recombinant Versus Synthetic: Two Different Quality ProblemsA recombinant protein has host cell proteins, DNA and endotoxin as impurities. A synthetic peptide has deletion sequences. The certificates should differ.
- IGF-1 LR3 Against the Native Hormone70 residues against 83, and a completely different relationship with binding proteins. Why one is an approved medicine and the other is not.
- Why LR3 Exists: The Cell Culture ApplicationCultured cells secrete their own binding proteins, which sequester added IGF-1 unpredictably. An analogue that resists them gives consistent availability.
- IGF-1 LR3 Storage: A Folded Protein, Not a PeptideA folded protein can lose activity while remaining chemically intact. Why denaturation and adsorption matter more here than chemical degradation.